Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | TNKS | O95271 | 2/20 | 0.45 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.45 |
| ▸ | PIM1 | P11309 | 2/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.41 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KRAS | P01116 | 1/20 | 0.39 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2534139 | 0.83 | LIMK1 (0.44) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL16919853 | 0.83 | MAPT (0.54) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL16922290 | 0.81 | MAPT (0.53) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL19119483 | 0.80 | LIMK1 (0.57) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL2536243 | 0.80 | PIM1 (0.45) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL13992526 | 0.80 | EGFR (0.42) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL23487331 | 0.79 | MAPT (0.40) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL16919837 | 0.78 | MAPT (0.49) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL16902632 | 0.78 | ALDH1A1 (0.47) | MAPTTNKSTNKS2PIM1PIM2 | |
| SCHEMBL30646362 | 0.78 | ALDH1A1 (0.47) | MAPTTNKSTNKS2PIM1PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | DUK SAN NEOLUX CO., LTD (KR) | 2019-04-04 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | MAPT 954/4885TNKS 4285/4885TNKS2 3809/4885 |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | ORAI2, VDAC2, PIEZO1 | MAPT 954/4885TNKS 4285/4885TNKS2 3809/4885 |
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | ORAI2, VDAC2, PIEZO1 | MAPT 954/4885TNKS 4285/4885TNKS2 3809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.